Silverarc Capital Management as of March 31, 2024
Portfolio Holdings for Silverarc Capital Management
Silverarc Capital Management holds 77 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Merus N V (MRUS) | 7.1 | $26M | 566k | 45.03 | |
| Solid Biosciences Com New (SLDB) | 4.9 | $18M | 1.3M | 13.32 | |
| Morphic Hldg (MORF) | 4.7 | $17M | 484k | 35.20 | |
| Oric Pharmaceuticals (ORIC) | 4.3 | $15M | 1.1M | 13.75 | |
| Mersana Therapeutics | 3.7 | $13M | 3.0M | 4.48 | |
| Celldex Therapeutics Com New (CLDX) | 3.5 | $13M | 299k | 41.97 | |
| Avidity Biosciences Ord (RNA) | 3.5 | $13M | 489k | 25.52 | |
| Nuvalent Inc-a (NUVL) | 3.3 | $12M | 158k | 75.09 | |
| C4 Therapeutics Com Stk (CCCC) | 3.3 | $12M | 1.4M | 8.17 | |
| Praxis Precision Medicines I Com New (PRAX) | 3.2 | $12M | 191k | 61.02 | |
| Poseida Therapeutics I (PSTX) | 3.2 | $12M | 3.6M | 3.19 | |
| Akero Therapeutics (AKRO) | 2.8 | $10M | 400k | 25.26 | |
| IsoRay | 2.7 | $9.6M | 8.1M | 1.19 | |
| Rhythm Pharmaceuticals (RYTM) | 2.2 | $8.0M | 184k | 43.33 | |
| Alpine Immune Sciences | 2.2 | $7.9M | 199k | 39.64 | |
| Urogen Pharma (URGN) | 2.1 | $7.6M | 509k | 15.00 | |
| Gossamer Bio (GOSS) | 2.0 | $7.2M | 6.1M | 1.18 | |
| Macrogenics (MGNX) | 2.0 | $7.0M | 478k | 14.72 | |
| Cogent Biosciences (COGT) | 1.9 | $7.0M | 1.0M | 6.72 | |
| Kalvista Pharmaceuticals (KALV) | 1.8 | $6.7M | 561k | 11.86 | |
| Kodiak Sciences (KOD) | 1.8 | $6.5M | 1.2M | 5.26 | |
| Veracyte (VCYT) | 1.7 | $6.2M | 281k | 22.16 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.7 | $6.0M | 128k | 46.81 | |
| Olema Pharmaceuticals (OLMA) | 1.6 | $5.8M | 515k | 11.32 | |
| Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 1.4 | $5.2M | 500k | 10.40 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 1.4 | $5.1M | 248k | 20.67 | |
| Boundless Bio (BOLD) | 1.2 | $4.5M | 313k | 14.25 | |
| Tela Bio (TELA) | 1.2 | $4.4M | 777k | 5.67 | |
| Biogen Idec (BIIB) | 1.2 | $4.2M | 19k | 215.63 | |
| Fulcrum Therapeutics (FULC) | 1.0 | $3.8M | 398k | 9.44 | |
| Scholar Rock Hldg Corp (SRRK) | 1.0 | $3.5M | 199k | 17.76 | |
| Cytokinetics Com New (CYTK) | 1.0 | $3.5M | 50k | 70.11 | |
| Apogee Therapeutics (APGE) | 0.9 | $3.3M | 50k | 66.45 | |
| Jasper Therapeutics Com New (JSPR) | 0.9 | $3.2M | 110k | 29.36 | |
| Insmed Com Par $.01 (INSM) | 0.9 | $3.1M | 114k | 27.13 | |
| Wave Life Sciences SHS (WVE) | 0.8 | $3.1M | 496k | 6.17 | |
| Trevi Therapeutics (TRVI) | 0.8 | $2.9M | 844k | 3.45 | |
| Xenon Pharmaceuticals (XENE) | 0.8 | $2.8M | 66k | 43.05 | |
| Dex (DXCM) | 0.8 | $2.8M | 20k | 138.70 | |
| Cerus Corporation (CERS) | 0.8 | $2.8M | 1.5M | 1.89 | |
| Pliant Therapeutics (PLRX) | 0.8 | $2.7M | 183k | 14.90 | |
| Rocket Pharmaceuticals (RCKT) | 0.8 | $2.7M | 101k | 26.94 | |
| Compugen Ord (CGEN) | 0.7 | $2.6M | 1.0M | 2.58 | |
| Intra Cellular Therapies (ITCI) | 0.7 | $2.4M | 35k | 69.20 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.7 | $2.4M | 100k | 23.65 | |
| Evogene SHS | 0.6 | $2.3M | 3.1M | 0.75 | |
| Adc Therapeutics Sa SHS (ADCT) | 0.6 | $2.3M | 501k | 4.49 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.6 | $2.2M | 137k | 16.09 | |
| Macrogenics Call Call Option | 0.6 | $2.1M | 146k | 14.72 | |
| Mirum Pharmaceuticals (MIRM) | 0.6 | $2.0M | 79k | 25.12 | |
| Krystal Biotech (KRYS) | 0.5 | $1.8M | 10k | 177.93 | |
| Modular Med Com New (MODD) | 0.5 | $1.7M | 900k | 1.85 | |
| Terns Pharmaceuticals (TERN) | 0.5 | $1.6M | 251k | 6.56 | |
| Viking Therapeutics (VKTX) | 0.5 | $1.6M | 20k | 82.00 | |
| Amylyx Pharmaceuticals (AMLX) | 0.4 | $1.4M | 500k | 2.84 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.3 | $1.3M | 32k | 39.24 | |
| Fractyl Health (GUTS) | 0.3 | $1.2M | 167k | 7.40 | |
| C4 Therapeutics Call Call Option | 0.3 | $1.2M | 150k | 8.17 | |
| 89bio (ETNB) | 0.3 | $1.1M | 92k | 11.64 | |
| Abivax Sa Sponsored Ads (ABVX) | 0.3 | $1.1M | 75k | 14.30 | |
| Zura Bio Class A Ord Shs (ZURA) | 0.2 | $844k | 329k | 2.57 | |
| Karyopharm Therapeutics | 0.2 | $843k | 559k | 1.51 | |
| Geron Corporation (GERN) | 0.2 | $825k | 250k | 3.30 | |
| Molecular Templates Com New (MTEMQ) | 0.2 | $794k | 355k | 2.24 | |
| Adicet Bio (ACET) | 0.2 | $779k | 331k | 2.35 | |
| Mineralys Therapeutics (MLYS) | 0.2 | $735k | 57k | 12.91 | |
| Aligos Therapeutics | 0.2 | $642k | 656k | 0.98 | |
| Relmada Therapeutics (RLMD) | 0.1 | $462k | 99k | 4.65 | |
| Erasca (ERAS) | 0.1 | $461k | 224k | 2.06 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.1 | $429k | 10k | 42.86 | |
| Rezolute Com New (RZLT) | 0.1 | $388k | 152k | 2.55 | |
| Vyne Therapeutics (VYNE) | 0.1 | $265k | 86k | 3.07 | |
| Elutia Cl A Com (ELUT) | 0.1 | $248k | 79k | 3.15 | |
| Immunome (IMNM) | 0.1 | $185k | 7.5k | 24.68 | |
| Amylyx Pharmaceuticals Call Call Option | 0.0 | $57k | 20k | 2.84 | |
| Rocket Pharmaceuticals *w Exp 09/02/202 (RCKTW) | 0.0 | $31k | 105k | 0.30 | |
| Mersana Therapeutics Call Call Option | 0.0 | $7.6k | 1.7k | 4.48 |